The DOI matches its OpenAlex record; 1 of the 1 references it cites were found in a registry or an index.
Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus
Open accessAbstract
Aspirin has been previously shown to reduce the in vivo virulence of Staphylococcus aureus in experimental endocarditis, through antiplatelet and antimicrobial mechanisms. In the present study, salicylic acid, the major in vivo metabolite of aspirin, mitigated two important virulence phenotypes in both clinical and laboratory S. aureus strains: alpha-hemolysin secretion and fibronectin binding in vitro. In addition, salicylic acid reduced the expression of the alpha-hemolysin gene promoter, hla, and the fibronectin gene promoter, fnbA. Transcriptional analysis, fluorometry, and flow cytometry revealed evidence of salicylic acid-mediated activation of the stress-response gene sigB. Expression of the sigB-repressible global regulon sarA and the global regulon agr were also mitigated by salicylic acid, corresponding to the reduced expression of the hla and fnbA genes in vitro. Studies in experimental endocarditis confirmed the key roles of both sarA and sigB in mediating the antistaphylococcal effects of salicylic acid in vivo. Therefore, aspirin has the potential to be an adjuvant therapeutic agent against endovascular infections that result from S. aureus, by downmodulating key staphylococcal global regulons and structural genes in vivo, thus abrogating relevant virulence phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kupferwasser, L. I., Yeaman, M. R., Shapiro, S. M., Nast, C. C., Sullam, P. M., Filler, S. G., & Bayer, A. S. (1999) · Circulation · doi:10.1161/01.cir.99.21.2791 · Cited by 169
Self-citation
Research works printed but not linked: 52
- Brumfitt, 1989, N. Engl. J. Med., 320, 1188, 10.1056/NEJM198905043201806 · DOI · Paper page
- 10.1016/S0140-6736(97)07324-8 · DOI · Paper page
- 10.1126/science.280.5362.438 · DOI · Paper page
- 10.1056/NEJMoa011297 · DOI · Paper page
- 10.1126/science.8430319 · DOI · Paper page
- 10.1126/science.8052854 · DOI · Paper page
- 10.1006/viro.1997.8582 · DOI
- 10.1172/JCI117530 · DOI · Paper page
- Wolz, 1996, Infect. Immun., 64, 3142, 10.1128/IAI.64.8.3142-3147.1996 · DOI
- 10.2165/00003088-198510020-00004 · DOI · Paper page
- 10.1128/IAI.69.8.4742-4748.2001 · DOI
- Cheung, 1994, J. Bacteriol., 176, 4168, 10.1128/jb.176.13.4168-4172.1994 · DOI · Paper page
- 10.1073/pnas.89.14.6462 · DOI · Paper page
- Deora, 1997, J. Bacteriol., 179, 6355, 10.1128/jb.179.20.6355-6359.1997 · DOI
- Manna, 1998, J. Bacteriol., 180, 3828, 10.1128/JB.180.15.3828-3836.1998 · DOI
- 10.1128/JB.184.19.5457-5467.2002 · DOI · Paper page
- Bhakdi, 1991, Microbiol. Rev., 55, 733, 10.1128/MMBR.55.4.733-751.1991 · doi:10.1128/mmbr.55.4.733-751.1991 · Paper page
- Bayer, 1997, Infect. Immun., 65, 4652, 10.1128/IAI.65.11.4652-4660.1997 · DOI
- Menzies, 1994, Infect. Immun., 62, 1843, 10.1128/IAI.62.5.1843-1847.1994 · DOI
- Smeltzer, 1993, Infect. Immun., 61, 919, 10.1128/IAI.61.3.919-925.1993 · doi:10.1128/iai.61.3.919-925.1993
- Cheung, 1998, Infect. Immun., 66, 5988, 10.1128/IAI.66.12.5988-5993.1998 · DOI
- 10.1016/0378-1119(95)00685-0 · DOI · Paper page
- 10.1007/s004380051001 · DOI
- 10.1086/342046 · DOI
- Cheung, 1995, J. Bacteriol., 177, 3220, 10.1128/jb.177.11.3220-3226.1995 · DOI
- Cheung, 1997, J. Bacteriol., 179, 3963, 10.1128/jb.179.12.3963-3971.1997 · DOI
- Cheung, 1999, Infect. Immun., 67, 1331, 10.1128/IAI.67.3.1331-1337.1999 · DOI
- Farber, 1992, J. Infect. Dis., 166, 861, 10.1093/infdis/166.4.861 · DOI
- Domenico, 1989, Infect. Immun., 57, 3778, 10.1128/IAI.57.12.3778-3782.1989 · DOI · Paper page
- 10.1128/AAC.45.11.3262-3266.2001 · DOI
- Nicolau, 1993, Infect. Immun., 61, 1593, 10.1128/IAI.61.4.1593-1595.1993 · DOI
- Cohen, 1993, J. Bacteriol., 175, 7856, 10.1128/jb.175.24.7856-7862.1993 · DOI · Paper page
- 10.1111/j.1574-6968.2001.tb10843.x · DOI
- Gustafson, 1999, Antimicrob. Agents Chemother., 43, 990, 10.1128/AAC.43.4.990 · doi:10.1128/aac.43.4.990
- 10.1128/IAI.70.6.2758-2762.2002 · DOI · Paper page
- 10.1074/jbc.275.18.13863 · DOI · Paper page
- 10.1128/JB.182.24.6983-6991.2000 · DOI · Paper page
- 10.1074/jbc.273.5.2645 · DOI · Paper page
- Bayer, 1996, J. Bacteriol., 178, 4563, 10.1128/jb.178.15.4563-4570.1996 · DOI · Paper page
- 10.1074/jbc.274.52.37169 · DOI · Paper page
- 10.2741/cheung · DOI
- 10.1128/JB.183.24.7341-7353.2001 · DOI · Paper page
- Kullik, 1998, J. Bacteriol., 180, 4814, 10.1128/JB.180.18.4814-4820.1998 · DOI · Paper page
- 10.1046/j.1365-2958.1996.396932.x · DOI · Paper page
- 10.1128/IAI.69.12.7858-7865.2001 · DOI
- Booth, 1997, Infect. Immun., 65, 1550, 10.1128/IAI.65.4.1550-1556.1997 · DOI
- Wu, 1996, J. Bacteriol., 178, 6036, 10.1128/jb.178.20.6036-6042.1996 · DOI · Paper page
- Dhawan, 1997, Infect. Immun., 65, 3293, 10.1128/IAI.65.8.3293-3299.1997 · DOI
- Koo, 1996, Infect. Immun., 64, 1070, 10.1128/IAI.64.3.1070-1074.1996 · DOI
- 10.1111/j.1365-2958.1994.tb00304.x · DOI · Paper page
- Chambers, 1987, Antimicrob. Agents Chemother., 31, 1919, 10.1128/AAC.31.12.1919 · DOI
- 10.1086/315812 · DOI
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationMicroarray-Based Analysis of the Staphylococcus aureus σBRegulon
Bischoff, M., Dunman, P., Kormanec, J., Macapagal, D., Murphy, E., Mounts, W., Berger-Bächi, B., & Projan, S. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.13.4085-4099.2004 · Cited by 401
Platelets: at the nexus of antimicrobial defence
Yeaman, M. R. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3269 · Cited by 352
Self-citation
Metadata
- Authors
- Kupferwasser, L. I., Yeaman, M. R., Nast, C. C., Kupferwasser, D., Xiong, Y.-Q., Palma, M., Cheung, A. L., & Bayer, A. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-15
- Volume
- 112
- Issue
- 2
- Pages
- 222-233
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2003882473
- Cited by
- 182
- References
- 1
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. https://app.cochat.ai/papers/10.1172/jci16876
- The paper
- Kupferwasser, L. I., Yeaman, M. R., Nast, C. C., Kupferwasser, D., Xiong, Y.-Q., Palma, M., Cheung, A. L., & Bayer, A. S. (2003). Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. Journal of Clinical Investigation. https://doi.org/10.1172/jci16876
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.